Guangdong Jiaying Pharmaceutical Co., Ltd
002198.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.8B
Close$
$0.74
78.5% downside
Current Fair Value
78.5% downsideOvervalued by 78.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.80 Billion |
|---|---|
| Enterprise Value | $1.70 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.06 |
| Beta | -0.02 |
| Outstanding Shares | 377,721,539 |
Return
| Return on Equity | -0.37% |
|---|---|
| Return on Assets | -0.30% |
| Return on Invested Capital | 0.41% |
Valuation & Multiples
| P/E Ratio | -122.41 |
|---|---|
| PEG | 19.02 |
| Price to Sales | - |
| Price to Book Ratio | 3.44 |
| Enterprise Value to Revenue | 4.84 |
| Enterprise Value to EBIT | 560.32 |
| Enterprise Value to Net Income | -657 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guangdong Jiaying Pharmaceutical Co., Ltd
594 employees
CEO: Yong Ping You Guangdong Jiaying Pharmaceutical Co., Ltd. is engaged in the comprehensive process of researching, developing, manufacturing, and marketing traditional Chinese medicines. Its operations span a vast international territory, encompassing M...